This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel Agents in ER+/HER2- BC

0 views
June 14, 2024

Chapters

ER+/HER2- BC: Novel Agents & Trials

00:00

NSCLC: LAURA Trial & Osimertinib Results

05:41

NSCLC: CROWN Trial & Lorlatinib Efficacy

08:59

CRC: HERKULES-3 Trial & BRAF V600E

11:47

Tumor Agnostic Precision Oncology Advances

14:44

ASCO 2024 Highlights & Future Outlook

16:24

Comments 0
Login to view comments. Click here to Login